Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Response to Press Speculation

6 Apr 2016 07:00

RNS Number : 2902U
Strat Aero PLC
06 April 2016
 

Strat Aero plc / Index: AIM / TIDM: AERO / Sector: Support Services

6 April 2016

Strat Aero plc ("Strat Aero", the "Company" or the "Group")

 Response to Press Speculation and further information in connection with litigation

 

Strat Aero Plc, the AIM quoted international aerospace company focused on the Unmanned Aerial Vehicle ("UAV") sector, notes the recent speculation in the media following the Company's announcement of 1 April 2016.

 

Legal action against Mr. W. Hulsey Smith

 

As announced on 1 April 2016 the Company has filed a legal action against Mr W. Hulsey Smith, former Chairman and CEO of Strat Aero's subsidiary Aero Kinetics. The Company's action alleges counts of fraud and breach of contract arising from misrepresentations made by Mr. Smith upon which the Company relied and were material in the Company's decision to acquire Aero Kinetics.

 

There are a number of potential resolutions available to the Company in relation to the legal action including rescission of the purchase of Aero Kinetics as well as actual and consequential damages. The current action filed may also be amended going forward. The Company expects that Mr. Smith may launch some form of counterclaim but the board has received advice that such a claim would be unlikely to have any merit.

 

The Board strongly believes it has a robust legal position and will update the market as legal action progresses and as its plans for the Aero Kinetics business evolve in accordance with its regulatory obligations.

 

Funding

The Company has sufficient cash resources for the near term and the board expects to raise further funds in the current quarter to provide working capital in support of the continued growth of the Group's businesses. The Board is evaluating potential funding options, which may include the issue of equity, and will provide further updates as appropriate in due course.

 

Strategy

The current Board of Strat Aero, is made up of highly experienced executives who have held senior management positions in blue chip companies including Microsoft and Vodafone. The Board, is focused on implementing the Company's strategy, led by Iain McLure, the Company's newly appointed Chief Executive Officer. This strategy is centred on attracting new customers across its divisions bringing our significant experience and expertise in the UAV sector to new industries and new markets.

 

- ENDS -

 

For further information please visit www.strat-aero.com of contact:

 

Strat Aero plc

Tel: +44 (0) 1293 804741

Graham Peck (Chairman)

 

SP Angel Corporate Finance LLP

Tel: +44 (0) 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Jeff Keating

Beaufort Securities Limited

Tel: +44 (0) 20 7382 8300

Joint Broker

Elliot Hance

St Brides Partners Ltd

Tel: +44 (0) 20 7236 1177

Financial PR

Frank Buhagiar

Susie Geliher

 

Notes

Strat Aero plc is a multi-divisional international aerospace services company, focussed primarily on the provision of complete client solutions in the Unmanned Aerial System ('UAS' market), which is predicted to show exponential growth over the coming decade. Commercial and military applications in UASs are expected to be a dynamic growth sector in the aerospace industry over the next 10 years with the UAS market forecast to grow to more than US$82.1 billion between 2015 and 2025 (AUVSI Economic Report 2013) and the global airborne Intelligence, Surveillance and Reconnaissance ('ISR') market estimated to grow to US$19.23 billion by 2023.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCSSSEEIFMSEEL
Date   Source Headline
24th Feb 202111:05 amRNSSecond Price Monitoring Extn
24th Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20211:00 pmRNSUpdate on commissioning and board changes
12th Feb 20212:05 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
12th Feb 20211:12 pmRNSResult of General Meeting
12th Feb 20217:00 amRNSGeneral Meeting – Link for webinar
9th Feb 20215:56 pmRNSShareholders’ Questions and Answers
8th Feb 20211:23 pmRNSExercise of Options
1st Feb 20211:08 pmRNSExercise of Options
1st Feb 20217:00 amRNSCommissioning delayed
29th Jan 20217:00 amRNSTotal Voting Rights
27th Jan 20217:00 amRNSNotice of General Meeting
26th Jan 20217:00 amRNSExercise of Options
25th Jan 20213:29 pmRNSExercise of Options
25th Jan 20217:00 amRNSExercise of Warrants
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 202112:56 pmRNSEN14683 Certification, Commissioning Update
22nd Jan 20217:00 amRNSShare Option Grant update
21st Jan 20219:06 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 20217:00 amRNSBoard appointment,update on mask production and GM
11th Jan 20216:26 pmRNSDirector Dealing
11th Jan 20217:00 amRNSBoard changes
8th Jan 20215:00 pmRNSDirector Option Exercise and Total Voting Rights
8th Jan 20217:00 amRNSDirector Option Exercise and Total Voting Rights
7th Jan 202110:52 amRNSStatement regarding share price movement
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20217:00 amRNSPharm 2 Farm Update
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
31st Dec 202011:51 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSPlanned Board Changes & Warrant Update
29th Dec 20207:00 amRNSPharm 2 Farm Update
23rd Dec 20208:13 amRNSUpdate on Fundraising & response to announcements
18th Dec 202011:05 amRNSSecond Price Monitoring Extn
18th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20209:51 amRNSPlacing to raise £5,000,000 and Issue of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.